Health tech stocks including Hims, Teladoc, Amwell & GoodRx drop >5% amid market volatility from Trump tariffs. Hinge Health reportedly delays IPO plans as sector faces uncertainty.Read More
What stock market chaos means for health tech
By Ngai Yeung
